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In 2003, governments adopted the Framework Convention on Tobacco Control, the world’s first global health treaty.
In the decade since the treaty was adopted by 178 member states of the World Health Organization, there have been
substantial achievements in reducing tobacco use around the world. Research and evidence on the impact of
interventions and policies have helped drive this policy progress. An increased and sustained focus on research is
needed in the future to ensure that the gains of the global tobacco control movement are maintained, particularly in
low- and middle-income countries, which are affected most strongly by the tobacco epidemic. In addition to current
priorities, greater attention is needed to research related to trade agreements, prevention among girls, and the
appropriate response to nicotine-based noncombustibles (including e-cigarettes).
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The background to this article is a workshop held at the
National Institutes of Health (NIH) in June 2013 to review
progress and achievements in global tobacco control
research in low- and middle-income countries (LMICs)
over the last decade. The commentary is informed by
some of the key themes that emerged from this discussion
complemented by our views about future priorities for
tobacco control research.
In 2003, governments adopted the World Health Orga-
nization’s Framework Convention on Tobacco Control
(WHO FCTC) [1] to “protect present and future gener-
ations from the devastating consequences of tobacco
consumption and exposure” [2]. At that time, up to 1
billion tobacco deaths were projected to occur in the
21st century absent sustained action to reduce rates of
tobacco use; approximately 80% of these deaths will
occur in LMICs. The FCTC’s development was based on
the best available epidemiologic and economic evidence
on the impact of interventions and policies [3-5], along
with insights drawn from analyses of tobacco industry
behavior in thwarting past efforts to advance tobacco
control [6,7].* Correspondence: dyach@thevitalitygroup.com
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unless otherwise stated.The FCTC specifically highlighted ongoing research,
surveillance, and the exchange of information as being
critical to tobacco control. For example, the Convention
advised countries to establish national systems for the
epidemiologic surveillance of tobacco consumption and
related social, economic, and health indicators. Countries
were also advised to cooperate with competent inter-
national and regional intergovernmental organizations
and other bodies, including governmental and nongovern-
mental agencies, in regional and global tobacco surveillance
and exchange of information on these indicators. The
FCTC also emphasized the exchange of publicly available
scientific, technical, socioeconomic, commercial, and legal
information, as well as information regarding practices of
the tobacco industry and the cultivation of tobacco. This
exchange should take into account and address the special
needs of developing countries and those with economies
in transition [8]. Specific research priorities have not been
developed by the Conference of the Parties to the FCTC.
Rather, research bodies have set priorities based on
strengthening the most effective FCTC interventions,
many of which are now included under the MPOWER
program (Table 1) [9], and by drawing on experts’
opinions [10-12].
In this article, we reflect on the role of research in
advancing tobacco control, both in the successes to date
of the global tobacco control movement and, in light of
these, the research priorities that are needed to underpind. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 The six components of MPOWER [9]
1. ● Monitor tobacco use and prevention policies
2. ● Protect people from tobacco smoke
3. ● Offer help to quit tobacco use
4. ● Warn about the dangers of tobacco
5. ● Enforce bans on tobacco advertising, promotion, and sponsorship
6. ● Raise taxes on tobacco
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views mindful of several negative trends in tobacco use
prevalence and of the need for, and new opportunities to
develop, innovative approaches to implementing tobacco
control policies in many LMICs.
Current situation
A decade after adoption of the FCTC, global tobacco
control is at a critical juncture. Smoking prevalence
in many high-income countries is decreasing, but in
most LMICs this is not the case [12]. In fact, the glo-
bal burden of disease attributable to tobacco smoking
has not changed significantly, because the decreases in
high-income regions are offset by increases in low-
income regions, such as Southeast Asia and East and
South Asia [13].
Funding for international tobacco control research
initially came from Canada’s International Development
Research Centre, which initiated Research for Inter-
national Tobacco Control to address the economic and
development aspects of tobacco control [14]. The most
significant globally available investment came from the
NIH’s Fogarty Center for International Health [15].
Additionally, for more than a decade, the U.S. Centers
for Disease Control and Prevention has funded and
managed the Global Youth Tobacco Surveys and Global
Adult Tobacco Surveys in more than180 countries [16].
Although the United States has been a supporter of
research and surveillance along with only a few major
countries (including Russia and Indonesia), it has yet to
adopt the FCTC.
Around the time the FCTC was adopted by WHO and
at the request of WHO, there were notable increased
investments in global tobacco control research and sur-
veillance. These included support through the Centers
for Disease Control and Prevention for tobacco surveillance
(initially focused on youth and later expanded with the
support of Bloomberg Philanthropies and the Bill and
Melinda Gates Foundation to include adults) and through
the NIH Fogarty International Center’s International
Tobacco and Health Research and Capacity Building
(TOBAC) program, which was initiated in partnership
with the National Cancer Institute (NCI) and the National
Institute on Drug Abuse to fund tobacco control research
and capacity building in LMICs.Surveillance issues
Over the last decade, the prevalence of tobacco use has
declined by 10% in Organization for Economic Cooper-
ation and Development countries and increased by 18%
in LMICs [17]. By 2010, smoking had become one of the
leading risk factors for disease burden in many low- and
middle-income regions, including Southeast Asia and
East and South Asia [13,17].
From 1990 to 2010, smoking increased from the fifth
to the third leading cause of disability-adjusted life
years in developing countries [18]. Media interest (as
measured through Google trends) and some Organization
for Economic Cooperation and Development countries’
investments in tobacco control in general and research in
particular have dwindled, but, against this harsh reality,
there have been policy research and implementation
progress that could reverse the negative trends.
Progress on expanding the reach and frequency of
surveillance has been impressive, with more than 180
countries now covered by the Global Youth Tobacco
Survey [16], 80 of which have carried out at least 3
rounds of surveys, and 32 countries now covered by the
Global Adult Tobacco Survey [17], of which 19 have
completed the survey. The WHO STEPwise approach
to chronic disease risk factor surveillance has also been
widely adopted in LMICs [19].
Basic epidemiologic surveillance data remain the cor-
nerstone of assessing progress and mobilizing action in
every country. There is a continued need to support
LMICs in strengthening both their national surveillance
capacity and their capacity to ensure that data are used
more widely to assess the impact of policies and make
them more effective. A shift in how health departments
use youth tobacco survey data is needed. They could
learn from the high degree of urgency and action that
is driven by infectious disease surveillance data.
Tobacco control is a new and still developing academic
discipline in most LMICs, with the majority of researchers
having less than six years of experience conducting
tobacco control research, indicating that support for
tobacco control education and between-country collabor-
ation is vital to progress [11]. The International Tobacco
Control (ITC) Project [20] is an example of this approach.
It measures the psychosocial and behavioral impact of
key national-level policies of the FCTC. The ITC Project
includes international health organizations and policy-
makers in more than 20 countries inhabited by more
than 50% of the world’s population, 60% of the world’s
smokers, and 70% of the world’s tobacco users. In each
country, the ITC Project is conducting prospective cohort
surveys to assess the impact and identify the determinants
of effective tobacco control policies on smoke-free legisla-
tion, health warning labels, pricing and taxation, cessation,
advertising/promotion, and communication/education. ITC
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tions and disinformation from the tobacco industry in
their fight against effective tobacco control policies and
has initiated an eight-year cohort survey of more than
6,000 adult smokers to guide effective policies in Canada,
the United States, the United Kingdom, and Australia,
including evaluation of new national policies enacted
under the U.S. Food and Drug Administration’s (FDA’s)
Family Smoking Prevention and Tobacco Control Act [21].
Research and capacity building
The importance of investing in research to address global
tobacco control effectively cannot be overstated. Put
simply, the WHO FCTC is an evidence-based document:
there is a need to ensure that the evidence base which
supports its continued implementation is up to date,
robust, and responsive to new and emerging challenges
and issues.
For example, there is now compelling evidence of the
impact and high value of the $40 million investment the
NIH has made in tobacco control research and capacity
development through the TOBAC program. This initiative
includes the development of new research insights and
knowledge, reflected in 405 peer-reviewed publications;
the training of 3,519 researchers and policy makers; 34
grants awarded for research and capacity building in
more than 30 countries, with support for new regional and
global networks of researchers; and, just as importantly,
evidence of the cumulative impact of this investment on
informing new and effective tobacco control policies. The
program invests in empiric research and capacity building
simultaneously, awarding funds for five-year periods to
allow researchers to build strong regional relationships and
develop trust in partnering countries.
The majority of the research projects funded have
been conducted in countries in East Asia, the Pacific,
South Asia, Latin America, and the Caribbean. TOBAC
has stimulated development of a young cadre of tobacco
control researchers across the world who have started to
impact the course, content, and focus of national tobacco
control policies. TOBAC-funded scientists from India,
Argentina, South Africa, and Uruguay have all played
important roles in FCTC delegations. From 2002 through
2012, the initiative’s $40 million dollar investment has
generated powerful outcomes. For example, in Hungary, a
country with some of the highest smoking rates in Europe,
TOBAC-funded researchers demonstrated taxes to be
an effective policy intervention for reducing smoking
prevalence. The findings were presented to legal and
public health officers in the local governments, and,
consequently, tobacco sales taxes were increased nine
times in the next four years. In addition, after engagement
with local researchers trained in the TOBAC program, the
State Secretary’s cabinet passed national clean air laws thatprotect nonsmokers in public places [15]. While Hungary
held the leading smoking rates in Europe, there were
301 million current smokers in China in 2010 [22]. China
is currently the largest manufacturer and consumer of
tobacco in the world, signaling an urgent need for tobacco
control research in this population [23].
It is critical to maintain and expand support for this type
of research at country level by governments, funding
agencies, and other stakeholders to address emerging
global research needs and opportunities. Recent reviews
have highlighted the importance of investing in country-
specific surveillance and research [24], which can be used
to stimulate local political action and support for tobacco
control in otherwise crowded policy arenas. Operational re-
search to support expedited implementation and maximum
impact of each of the major FCTC articles is critical. This is
especially true for those that underpin sustained increases
in tobacco product prices; guide development of marketing
regulations and tackle brand visibility and the explosion
in social media and internet marketing more effectively;
stimulate implementation of smoke-free policies, includ-
ing in homes; integrate tobacco control into major disease
management programs such as for cardiovascular disease,
cancers, tuberculosis, and maternal and child health; and
inform development of trade agreements.
Country-specific research also needs to be complemen-
ted by global research focused on emerging technologies
and trends. These include innovations such as social
media and smartphones, all of which have the potential
to be tools for tobacco control, although they also are
also being used by the tobacco industry to promote their
products. Smartphones can be used to enhance cessation
effectiveness and long-term maintenance, especially if
combined with behavioral economic measures [25]. For
example, the NCI has launched SmokefreeTXT, a free
text message smoking-cessation service, which provides
around-the-clock encouragement, advice, and tips to
teens trying to quit smoking. In addition, the NCI has
developed an interactive text messaging library and
delivery algorithm for adults in the United States who
wish to quit smoking. Similarly, the WHO has launched
the mHealth for NCDs program, designed to leverage
mobile technology to improve prevention and manage-
ment of noncommunicable diseases. Mobile phones can
also be used in novel ways to stimulate citizen involvement
in enforcing tobacco regulations, especially in settings
where enforcement capacity is weak. However, smart-
phones, social media, and gaming also provide new
ways of personalizing the marketing of tobacco products
even as smoking in movies is addressed.
Innovation also supports growth and continued profit-
ability of the tobacco industry, yet that is rarely studied
on a systematic basis and with the intent of adjusting
policies to changes in industry tactics and dynamics. We
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monitoring tobacco industry actions that is linked to
high-profile reporting is consistent with FCTC article
5.3. Without such research, the FCTC may well have
lacked many provisions.
Emerging issues
Three other trends demand urgent and substantial
research: the increase in tobacco use among girls and
women, the rapid emergence of electronic cigarettes
(e-cigarettes), alternative nicotine-delivery mechanisms;
and the emergence of trade law challenges [26-28].
The FCTC does not explicitly refer to trade policy.
However, a preambular line designed to give priority
to their right to protect public health was included to
signal the importance of tobacco control in all aspects
of development [1]. In 2003, World Trade Organization
Director-General Supachai Panitchpakdi publicly congrat-
ulated the WHO on FCTC ratification, stating, “When
dealing with the pressing problems of our age, whether
they relate to improving health standards or eradicating
poverty, there can be no doubt that the nations of the
world must work together. A multilateral approach to
problem solving offers all of us the best hope for a better
world” [29]. In concert with this statement, the FCTC
adoption provides a rationale for having the evidence-
based interventions in the FCTC take precedence over
legal challenges to their use. Such disputes are currently
materializing with respect to Australia’s law to introduce
plain packaging of tobacco products, and Uruguay’s intro-
duction of stronger graphic health warnings – both in
the WTO and through dispute resolution mechanisms
under a series of bilateral investor-state agreements
[30-32]. Research on trade, international, mercantile, and
domestic law must be made a priority if the integrity
and intent of the FCTC to “protect public health” is to
be maintained.
The ratio of smoking among boys to that among girls
has narrowed and in some cases reversed compared with
the ratio for their parents’ generation in all countries for
which there are data available [12,16,17]. This portends
a massive increase in tobacco deaths among women
decades from now. Deeper insights into the driving
forces behind these epidemiologic trends are urgently
required if more effective policies are to be developed.
One reason may relate to use of the pack as a marketing
tool (especially in places where there are restrictions on
traditional or direct advertising, promotion and spon-
sorship) – for example, the globalization of “Slim”
brands based on Virginia Slims, developed more than
four decades ago – a trend which is now increasingly
visible in many emerging markets. Novel use of the
pack in marketing may play a more important role in
increases in smoking among women than previouslyunderstood. The FCTC acknowledges the need “to take
measures to address gender-specific risks when developing
tobacco control strategies (Article 4)” [33], as well as to
restrict marketing through the pack itself (Article 11) [34].
The alarming increase in tobacco use among girls
demands both political action and focused research
[35-37]. In many countries where tobacco use among
women is still relatively low, the potential to shape its
status as the desired social norm still exists. In countries
where rates have increased, the voice and visibility of
women in leadership positions in business, politics, sports,
fashion, and entertainment in support of tobacco control
need to be stimulated. Despite the FCTC’s declaration of
commitment to addressing gender disparities, there is a
void in research on the drivers of tobacco use among
girls beyond the globalization of thin cigarettes and the
empowerment of women. There is a need to engage
institutions such as the United Nations Entity for Gender
Equality and the Empowerment of Women, in research
and action which on increasing rates of tobacco use
among girls and women in the context of the Convention
on the Elimination of Discrimination against Women.
Similarly, the FCTC preamble on “the Convention on the
Rights of the Child” provides that state parties to that
convention “recognize the right of every child to the
enjoyment of the highest attainable standards of health”
[1], and thus there is a need for the tobacco control
community to strengthen collaboration with the United
National Children’s Emergency Fund in light of mounting
evidence linking maternal tobacco use to low birthweight
and other adverse childhood health outcomes. Failure
will condemn millions of women and children to die
and suffer in the next few decades.
There is a need for well-designed studies on the safety,
efficacy, and impact of use (including long-term use)
of new nicotine-delivery systems, including e-cigarettes.
Sound policy must be based on sound science. At this
stage, despite the rapid emergence of a multibillion dollar
new revenue category [38], the evidence required to estab-
lish sound policy is still evolving.
The potential exists for e-cigarettes to become a useful
technology capable of substantially reducing the harm
caused by tobacco. However, there are concerns that it
could undermine the successes of tobacco control policies
to date (in particular with respect to denormalization of
smoking and decreasing youth smoking), and the evidence
on the health impact of e-cigarette use including over the
long term is still relatively sparse. In the United States,
Congress has released findings that some companies are
boosting advertising aimed at youth [39], and the FDA
has recently announced draft regulations on e-cigarettes.
Other countries and jurisdictions are also grappling with
the question of how to regulate these products, in the
context of their existing regulatory systems and the
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their use (including over the long term). The need for
further research in this area is urgent, so that all countries
considering regulatory strategies in relation to e-cigarettes
and other electronic nicotine-delivery systems can be
informed by the best, most up to date, evidence (noting
that regulatory responses may also need to evolve over
time as the evidence base continues to develop).
Conclusions
In the decade since the WHO FCTC was adopted, sub-
stantial progress in tobacco control research and policy
action has been made, but the overall level of investment
in tobacco control research remains miniscule contrasted
with the need and the resources of the tobacco industry.
Recent research indicates that noncommunicable diseases
generally receive a tiny fraction of total Official Develop-
ment Assistance, and a very small percentage of this
funding is allocated to research. In 2007, a mere 2.3% of
overall development assistance for health was dedicated to
all noncommunicable diseases [40]. Most LMICs lack
the basic capacity for any tobacco control research, and
major disciplinary gaps in behavioral sciences, economics,
and law impede progress in developing policy-relevant
research. Tobacco control needs to learn urgently from
HIV/AIDS, malaria, and nutrition about the value and
power of bringing together leading philanthropic founda-
tions, development agencies, national research bodies,
and appropriate private sector interests in an alliance to
address the massive needs discussed here.
There are simply no better opportunities in global health
to prevent up to a billion deaths in this century.
Abbreviations
FCTC: Framework convention on tobacco control; FDA: U.S. Food and Drug
Administration; ITC: International Tobacco Control Project; LMICs: Low- and
middle-income countries; NCI: National Cancer Institute; NIH: National Institutes of
Health; TOBAC: (Fogarty International Center’s) International Tobacco and Health
Research and Capacity Building program; WHO: World Health Organization.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
DY and AP led the drafting of the manuscript, and all other authors
contributed to the development and finalization of the manuscript. All
authors read and approved the final manuscript.
Authors’ note
The views expressed in this article are those of the authors and do not
necessarily reflect the position or policy of the NIH, the Fogarty International
Center, the WHO, or participants at the NIH-Fogarty workshop held in June
2013 on which some of the themes and conclusions in the article are based.
Acknowledgements
We thank Vera Oziransky for exceptional editorial support and the reviewers
for sage comments.
Author details
1The Vitality Group, New York, New York, USA. 2The Vitality Institute, New
York, New York, USA. 3Tobacco Free Initiative, WHO, Beijing, China. 4CancerScience and Trends, American Cancer Society, New York, New York, USA.
5Public Health Foundation of India, New Delhi, India. 6World Heart
Federation, Geneva, Switzerland.
Received: 7 March 2014 Accepted: 12 May 2014
Published: 21 May 2014
References
1. WHO: Framework Convention on Tobacco Control 2003, Updated reprint
2004, 2004 ed. Geneva, Switzerland: World Health Organization; 2003.
2. WHO: Framework Convention on Tobacco Control 2003 Article 3, Updated
reprint 2004, 2005 ed. Geneva, Switzerland: World Health Organization; 2003.
3. Murray CJ, Lopez AD: Mortality by cause for eight regions of the world:
Global Burden of Disease Study. Lancet 1997, 349(9061):1269–1276.
4. Murray CJ, Lopez AD: Global mortality, disability, and the contribution of risk
factors: Global Burden of Disease Study. Lancet 1997, 349(9063):1436–1442.
5. World Bank: Curbing the Epidemic: Governments and the Economics of
Tobacco Control. Washington, DC: World Bank Publications; 1999.
6. Committee of Experts on Tobacco Industry Documents, World Health
Organization: Tobacco Company Strategies to Undermine Tobacco Control
Activities at the World Health Organization. San Francisco, CA: Tobacco
Control; 2000.
7. Bialous SA, Yach D: Whose standard is it, anyway? How the tobacco industry
determines the International Organization for Standardization (ISO)
standards for tobacco and tobacco products. Tob Control 2001, 10(2):96–104.
8. WHO: Framework Convention on Tobacco Control 2003 Article 20, Updated
reprint 2004, 2005 ed. Geneva, Switzerland: World Health Organization; 2003.
9. WHO: MPOWER brochures and other resources. Geneva, Switzerland: World
Health Organization; 2014. [http://www.who.int/tobacco/mpower/
publications/en/] (accessed May 2, 2014).
10. Samet JM, Yach D, Taylor C, Becker K: Research for effective global
tobacco control in the 21st century: report of a working group
convened during the 10th World Conference on Tobacco or Health.
Tob Control 1998, 7(1):72–77.
11. Stillman F, Wipfli H, Samet J: Reaching and educating the global tobacco
control community: innovative approaches to tobacco control training.
Public Health Rep 2006, 121(5):521–528.
12. Yach D: The origins, development, effects, and future of the WHO
Framework Convention on Tobacco Control: a personal perspective.
Lancet 2014, [http://dx.doi.org/10.1016/S0140-6736(13)62155-8]
(accessed May 2, 2014).
13. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M,
Anderson HR, Andrews KG, Aryee M, Atkinson C, Bacchus LJ, Bahalim AN,
Balakrishnan K, Balmes J, Barker-Collo S, Baxter A, Bell ML, Blore JD, Blyth F,
Bonner C, Borges G, Bourne R, Boussinesq M, Brauer M, Brooks P, Bruce NG,
Brunekreef B, Bryan-Hancock C, Bucello C, et al: A comparative risk assessment
of burden of disease and injury attributable to 67 risk factors and risk factor
clusters in 21 regions, 1990–2010: a systematic analysis for the Global
Burden of Disease Study 2010. Lancet 2012, 380(9859):2224–2260.
14. Research for International Tobacco Control (RITC): Bridging the Research
Gaps in Global Tobacco Control: report on the meeting in Ottawa, Canada,
November 4–6, 2002. Ottawa, Ontario, Canada: RITC; 2002.
15. National Institutes of Health, Fogarty International Center: International Tobacco
and Health Research and Capacity Building Program review 2002–2012. Bethesda,
MD: NIH Fogarty Center Tobacco Control Research Symposium; 2013.
16. Warren CW, Asma S, Lee J, Lea V, Mackay J: Global Tobacco Surveillance
System–the GTSS atlas. Atlanta, GA, USA: CDC Foundation; 2009.
17. Giovino GA, Mirza SA, Samet JM, Gupta PC, Jarvis MJ, Bhala N, Peto R,
Zatonski W, Hsia J, Morton J, Palipudi KM, Asma S, GATS Collaborative
Group: Tobacco use in 3 billion individuals from 16 countries: an analysis
of nationally representative cross-sectional household surveys. Lancet
2012, 380(9842):668–679.
18. IHME: GBD Arrow Diagram. Seattle, WA: Institute for Health Metrics and
Evaluation; 2013. [http://www.healthmetricsandevaluation.org/gbd/
visualizations/gbd-arrow-diagram] (accessed May 2, 2014).
19. WHO: STEPwise approach to surveillance (STEPS). Geneva, Switzerland: World
Health Organization; 2014.
20. Fong GT, Cummings KM, Borland R, Hastings G, Hyland A, Giovino GA,
Hammond D, Thompson ME: The conceptual framework of the
International Tobacco Control (ITC) Policy Evaluation Project. Tob Control
2006, 15(3):iii3–iii11.
Yach et al. Globalization and Health 2014, 10:39 Page 6 of 6
http://www.globalizationandhealth.com/content/10/1/3921. International Tobacco Control Policy Evaluation Project. Waterloo, ON:
ITC; 2010. [http://www.itcproject.org/sites/default/files/files/ITC%20General%
20Brochure%20V5(1).pdf] (accessed May 2, 2014).
22. Global Tobacco Surveillance System: Global Adult Tobacco Survey. Fact
Sheet China 2010. [http://www.who.int/tobacco/surveillance/
en_tfi_china_gats_factsheet_2010.pdf?ua=1] (accessed May 2, 2014).
23. Tobacco Atlas: Manufacturing cigarettes. Chapter 17. [http://www.
tobaccoatlas.org/uploads/Files/pdfs/industry/manufacturing/
manufacturing_pdf.pdf] (accessed May 2, 2014).
24. Mackay J: Implementing tobacco control policies. Br Med Bull 2012, 102:5–16.
25. Volpp KG, Troxel AB, Pauly MV, Glick HA, Puig A, Asch DA, Galvin R, Zhu J,
Wan F, DeGuzman J, Corbett E, Weiner J, Audrain-McGovern J: A randomized,
controlled trial of financial incentives for smoking cessation. N Engl J Med
2009, 360(7):699–709.
26. Hammond D, Wakefield M, Durkin S, Brennan E: Tobacco packaging and
mass media campaigns: research needs for Articles 11 and 12 of the
WHO Framework Convention on Tobacco Control. Nicotine Tob Res 2013,
15(4):817–831.
27. Anderson SJ, Glantz SA, Ling PM: Emotions for sale: cigarette advertising
and women’s psychosocial needs. Tob Control 2005, 14(2):127–135.
28. Pozin I: Electronic Cigarettes: Booming Industry Or Health Fiasco? Forbes.
11 April 2013. [http://www.forbes.com/sites/ilyapozin/2013/04/11/electronic-
cigarettes-booming-industry-or-health-fiasco/] (accessed May 2, 2014).
29. World Trade Organization: Director General Supachai Welcomes WHO
Tobacco Agreement. 2014, World Trade Organization. [http://www.wto.org/
english/news_e/news03_e/sp_who_tobacco_agr_3march03_e.htm]
(accessed May 2, 2014).
30. Holding FTR SA, Products PM, Hermanos A: Oriental Republic of Uruguay.
Arbitration under the Rules of the International Centre for Settlement of
Investment Disputes. Lalive 2010. [http://www.arbitration.fr/resources/
ICSID-ARB-10-7-Notice-of-arbitration.pdf] (accessed May 2, 2014).
31. JT International SA v Commonwealth of Australia/British American
Tobacco Australasia Limited v The Commonwealth. 43(S409/2011. S389/
2011). High Court of Australia; October 2012. [http://www.austlii.edu.au/au/
cases/cth/HCA/2012/43.html#fnB420] (accessed May 2, 2014).
32. Fooks G, Gilmore AB: International trade law, plain packaging and
tobacco industry political activity: the Trans-Pacific Partnership.
Tob Control 2014, 23(1):e1.
33. WHO: Framework Convention on Tobacco Control 2003 Article 4, Updated
reprint 2004, 2005 ed. Geneva, Switzerland: World Health Organization; 2003.
34. WHO: Framework Convention on Tobacco Control 2003 Article 11, Updated
reprint 2004, 2005 ed. Geneva, Switzerland: World Health Organization; 2003.
35. Levy D, de Almeida LM, Szklo A: The Brazil SimSmoke policy simulation
model: the effect of strong tobacco control policies on smoking
prevalence and smoking-attributable deaths in a middle income nation.
PLoS Med 2012, 9(11):e1001336.
36. Blecher E: Targeting the affordability of cigarettes: a new benchmark for
taxation policy in low-income and-middle-income countries. Tob Control
2010, 19(4):325–330.
37. Leischow SJ, Ayo-Yusuf O, Backinger CL: Converging research needs across
framework convention on tobacco control articles: making research
relevant to global tobacco control practice and policy. Nicotine Tob Res
2013, 15(4):761–766.
38. Yach D: E-Cigarettes. A positive disruption to the market and health or a
distraction? Cornerstone J Sustainable Finance Bank 2014, 48–50. [http://
cornerstonecapinc.com/2014/03/e-cigarettes-a-positive-disruption-to-the-
market-and-health-or-a-distraction2/] (accessed May 2, 2014).
39. E-cigarettes: closing regulatory gaps. Lancet 2014, 383(9927):1438.
40. Nugent RA, Feigl AB: Where have all the donors gone? Scarce donor
funding for non-communicable diseases. Washington, D.C.: Center for
Global Development; 2010. [http://www.cgdev.org/sites/default/files/
1424546_file_Nugent_Feigl_NCD_FINAL.pdf] (accessed May 2, 2014).
doi:10.1186/1744-8603-10-39
Cite this article as: Yach et al.: Research to stop tobacco deaths.
Globalization and Health 2014 10:39.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
